Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients
Abstract Apomorphine, used to treat OFF episodes in patients with Parkinson's disease (PD), is typically administered via subcutaneous injections. Administration of an oromucosal solution could offer a non‐invasive and user‐friendly alternative. This two‐part clinical study evaluated the safety...
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Wiley
2024-05-01
|
| Sarja: | Clinical and Translational Science |
| Linkit: | https://doi.org/10.1111/cts.13796 |